Published in Int J Colorectal Dis on January 15, 2004
Signal transduction in pancreatic stellate cells. J Gastroenterol (2009) 1.36
Molecular regulation of pancreatic stellate cell function. Mol Cancer (2004) 1.23
Molecular determinants of the profibrogenic effects of endothelin-1 in pancreatic stellate cells. World J Gastroenterol (2009) 0.81
AP-1 function and regulation. Curr Opin Cell Biol (1997) 8.29
Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol (2001) 6.73
c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell (1988) 6.24
AP-1 in cell proliferation and survival. Oncogene (2001) 6.07
Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med (1993) 5.97
Smads: transcriptional activators of TGF-beta responses. Cell (1998) 5.33
Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology (2001) 4.44
The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol (2000) 4.11
The Stat family in cytokine signaling. Curr Opin Cell Biol (2001) 4.10
Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology (1998) 3.95
Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut (1998) 3.77
Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut (1999) 3.36
Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem Sci (2000) 2.24
Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol (1999) 2.12
JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J (2000) 2.05
Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage. Cell (2001) 1.79
Transcriptional regulation of hepatic stellate cell activation. Gut (2002) 1.66
Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut (2002) 1.66
Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology (2000) 1.55
Molecular mechanisms of liver fibrogenesis--a homage to the role of activated fat-storing cells. Digestion (1995) 1.53
The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. New insights into pathophysiology of an intriguing cell. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 1.49
Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. Gastroenterology (1997) 1.43
Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis. Lab Invest (2000) 1.40
Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene (2000) 1.31
Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J Hepatol (2000) 1.23
Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut (2002) 1.21
Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family. Gene Expr (1999) 1.11
Activation of the transcription factor NF-kappaB by the erythropoietin receptor: structural requirements and biological significance. Cell Signal (2001) 1.08
Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins. Hepatology (1999) 1.01
Integration of growth factor signals at the c-fos serum response element. Philos Trans R Soc Lond B Biol Sci (1996) 1.00
Regulation of pancreatic stellate cell function in vitro: biological and molecular effects of all-trans retinoic acid. Biochem Pharmacol (2003) 0.94
Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. Biochem Pharmacol (2003) 0.86
Interferon-alpha enhances biological defense activities against oxidative stress in cultured rat hepatocytes and hepatic stellate cells. J Med Invest (2002) 0.84
Differentiation modulates the balance of positive and negative Jun/AP-1 DNA binding activities to regulate cellular proliferative potential: different effects in nontransformed and transformed cells. J Cell Biol (1996) 0.83
Antiapoptotic effect of interferon-alpha on hepatic stellate cells (HSC): a novel pathway of IFN-alpha signal transduction via Janus kinase 2 (JAK2) and caspase-8. Eur J Cell Biol (2003) 0.82
Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment. Gut (2013) 2.28
StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut (2011) 2.07
The road from systems biology to systems medicine. Pediatr Res (2013) 1.70
Generation and characterization of immortalized rat pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol (2004) 1.15
Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation. World J Gastroenterol (2006) 1.04
Peroxisome proliferator-activated receptor gamma overexpression inhibits pro-fibrogenic activities of immortalised rat pancreatic stellate cells. J Cell Mol Med (2005) 1.02
Mathematical modelling of interferon-gamma signalling in pancreatic stellate cells reflects and predicts the dynamics of STAT1 pathway activity. Cell Signal (2009) 1.02
Molecular insights into connective tissue growth factor action in rat pancreatic stellate cells. Cell Signal (2008) 0.98
Systems biology of JAK-STAT signalling in human malignancies. Prog Biophys Mol Biol (2011) 0.96
Antifibrogenic effects of histone deacetylase inhibitors on pancreatic stellate cells. Biochem Pharmacol (2007) 0.96
Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial. Dig Dis Sci (2007) 0.94
Novel indolylmaleimide acts as GSK-3beta inhibitor in human neural progenitor cells. Bioorg Med Chem (2010) 0.94
Regulation of pancreatic stellate cell function in vitro: biological and molecular effects of all-trans retinoic acid. Biochem Pharmacol (2003) 0.94
Bone marrow-derived pancreatic stellate cells in rats. Cell Res (2010) 0.93
Systems biologists seek fuller integration of systems biology approaches in new cancer research programs. Cancer Res (2009) 0.92
Crucial role of fibrogenesis in pancreatic diseases. Best Pract Res Clin Gastroenterol (2008) 0.92
Inhibition of lymphocyte apoptosis by pancreatic stellate cells: impact of interleukin-15. Am J Physiol Gastrointest Liver Physiol (2005) 0.91
Studies on mechanisms of interferon-gamma action in pancreatic cancer using a data-driven and model-based approach. Mol Cancer (2011) 0.91
Inhibitory effects of interferon-gamma on activation of rat pancreatic stellate cells are mediated by STAT1 and involve down-regulation of CTGF expression. Cell Signal (2006) 0.90
Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease. Eur J Gastroenterol Hepatol (2007) 0.90
Adenovirus-mediated gene transfer of interleukin-4 into pancreatic stellate cells promotes interleukin-10 expression. J Cell Mol Med (2006) 0.86
Parameter identifiability and sensitivity analysis predict targets for enhancement of STAT1 activity in pancreatic cancer and stellate cells. PLoS Comput Biol (2012) 0.86
Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. Biochem Pharmacol (2003) 0.86
Synergistic growth inhibitory effects of the dual endothelin-1 receptor antagonist bosentan on pancreatic stellate and cancer cells. Dig Dis Sci (2008) 0.86
Identification of quantitative trait loci for murine autoimmune pancreatitis. J Med Genet (2011) 0.86
Galectin-1 is an inductor of pancreatic stellate cell activation. Cell Signal (2005) 0.86
Early rise in inflammation and microcirculatory disorder determine the development of autoimmune pancreatitis in the MRL/Mp-mouse. Am J Physiol Gastrointest Liver Physiol (2008) 0.85
Inhibitory effects of interferons on pancreatic stellate cell activation. World J Gastroenterol (2006) 0.85
Lysates of S. pyogenes serotype M49 induce pancreatic tumor growth delay by specific and unspecific antitumor immune responses. J Immunother (2008) 0.83
Aging is associated with a shift of fatty metabolism toward lipogenesis. J Gerontol A Biol Sci Med Sci (2011) 0.83
Inbred mouse strains reveal biomarkers that are pro-longevity, antilongevity or role switching. Aging Cell (2014) 0.82
Transforming growth factor-beta induces nerve growth factor expression in pancreatic stellate cells by activation of the ALK-5 pathway. Growth Factors (2009) 0.82
Interleukin-4 gene transfer into rat pancreas by recombinant adenovirus. Scand J Gastroenterol (2005) 0.82
In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy subjects. J Clin Apher (2005) 0.82
Molecular determinants of the profibrogenic effects of endothelin-1 in pancreatic stellate cells. World J Gastroenterol (2009) 0.81
Senescence determines the fate of activated rat pancreatic stellate cells. J Cell Mol Med (2012) 0.81
Interferon-gamma treatment accelerates and aggravates autoimmune pancreatitis in the MRL/Mp-mouse. Pancreatology (2009) 0.81
Insights into erlotinib action in pancreatic cancer cells using a combined experimental and mathematical approach. World J Gastroenterol (2012) 0.80
Industrial stabilizers caprylate and N-acetyltryptophanate reduce the efficacy of albumin in liver patients. Liver Transpl (2011) 0.80
The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor. J Biol Chem (2012) 0.79
Hydrogen peroxide-induced activation of defense mechanisms against oxidative stress in rat pancreatic acinar AR42J cells. Free Radic Biol Med (2006) 0.79
Molecular determinants of the antitumor effects of trichostatin A in pancreatic cancer cells. World J Gastroenterol (2010) 0.79
Interferon-alpha inhibits cell cycle progression by Ba/F3 cells through the antagonisation of interleukin-3 effects on key regulators of G(1)/S transition. Cell Signal (2002) 0.79
Reduction of dendritic cells by granulocyte and monocyte adsorption apheresis in patients with ulcerative colitis. Dig Dis Sci (2008) 0.78
Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Liver Transpl (2008) 0.78
Metastatic pancreatic carcinoma presenting as thrombotic thrombocytopenic purpura. Pancreas (2003) 0.78
Autoimmune diseases in gastroenterology. Curr Pharm Des (2012) 0.77
Immunologic characterization of acute pancreatitis in rats induced by dibutyltin dichloride (DBTC). Pancreas (2003) 0.77
The fate of effector T cells in vivo is determined during activation and differs for CD4+ and CD8+ cells. J Immunol (2002) 0.77
Vegetable stalk as a nidus for gallstone formation in a patient with a juxtapapillary duodenal diverticulum. Gastrointest Endosc (2002) 0.77
In vivo characterization of developing chronic pancreatitis in rats. Lab Invest (2005) 0.76
Cis-hydroxyproline-induced inhibition of pancreatic cancer cell growth is mediated by endoplasmic reticulum stress. World J Gastroenterol (2006) 0.76
Cdkn1a is a key mediator of rat pancreatic stellate cell senescence. Pancreatology (2013) 0.76
Establishment of a novel extracorporeal bowel model to study luminal approaches to treat inflammatory bowel disease. Dis Model Mech (2013) 0.75
Anti-inflammatory effects of reactive oxygen species - a multi-valued logical model validated by formal concept analysis. BMC Syst Biol (2014) 0.75
Trametinib and dactolisib but not regorafenib exert antiproliferative effects on rat pancreatic stellate cells. Hepatobiliary Pancreat Dis Int (2015) 0.75
Interferon-alpha inhibits interleukin-3-induced proliferation of Ba/F3 cells in a protein kinase R-dependent manner. Cell Signal (2004) 0.75
First human application of a novel adsorptive-type cytapheresis module in patients with active ulcerative colitis: a pilot study. Ther Apher Dial (2013) 0.75
Delayed response toward activation stimuli in pancreatic stellate cells. Pancreas (2006) 0.75